Targeting nerve growth factor, a new option for treatment of osteoarthritis: a network meta-analysis of comparative efficacy and safety with traditional drugs

Objective: Osteoarthritis (OA) is the most common joint disease and leading cause of pain and disability in the elderly population. Most guidelines recommend the use of non-steroidal anti-inflammatory drugs (NSAIDs) and opioids for the non-operative treatment of OA. Monoclonal nerve growth factor (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Ziqin, Zhou, Jian, Long, Zeling, Li, Yihan, Sun, Jingjing, Luo, Yingquan, Wang, Wanchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835067/
https://www.ncbi.nlm.nih.gov/pubmed/33293475
http://dx.doi.org/10.18632/aging.202232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835067/
https://www.ncbi.nlm.nih.gov/pubmed/33293475
http://dx.doi.org/10.18632/aging.202232

Ejemplares similares